Requested OTC NSAID Labeling Includes Cardiac Risk, Front Panel Changes

Manufacturers of over-the-counter non-steroidal anti-inflammatory drugs should prominently identify their products as NSAIDs on packaging, according to an FDA request

More from Archive

More from Pink Sheet